Molecular Imaging Identifies High-Risk Patients With Heart Disease

ScienceDaily (Aug. 10, 2010) — A study published in the August Journal of Nuclear Medicine (JNM) finds that molecular imaging — a non-invasive imaging procedure — can identify high-risk patients with potentially life-threatening cardiovascular conditions and help physicians determine which patients are best suited for implantable cardioverter defibrillator (ICD) therapy.

“If the molecular imaging techniques are used for appropriate selection of ICD candidates, not only overuse but also underuse of ICD could be avoided and the assessment may be shown to be more cost-effective,” said Kimio Nishisato, M.D., a physician in the cardiology division of Muroram City General Hospital, Muroram, Japan, and corresponding author for the study.

Click here to read the full article